Engineers Gate Manager’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-1,913
| Closed | -$19.4K | – | 2374 |
|
2024
Q4 | $19.4K | Sell |
1,913
-1,296
| -40% | -$13.1K | ﹤0.01% | 2159 |
|
2024
Q3 | $40K | Buy |
3,209
+1,296
| +68% | +$16.1K | ﹤0.01% | 1992 |
|
2024
Q2 | $24.9K | Hold |
1,913
| – | – | ﹤0.01% | 1844 |
|
2024
Q1 | $43.3K | Hold |
1,913
| – | – | ﹤0.01% | 1812 |
|
2023
Q4 | $24.8K | Sell |
1,913
-684
| -26% | -$8.88K | ﹤0.01% | 1892 |
|
2023
Q3 | $52.2K | Buy |
2,597
+1,669
| +180% | +$33.6K | ﹤0.01% | 1652 |
|
2023
Q2 | $24.9K | Buy |
+928
| New | +$24.9K | ﹤0.01% | 1659 |
|
2023
Q1 | – | Sell |
-3,303
| Closed | -$168K | – | 1834 |
|
2022
Q4 | $168K | Buy |
3,303
+1,250
| +61% | +$63.8K | 0.01% | 1417 |
|
2022
Q3 | $168K | Sell |
2,053
-1,209
| -37% | -$98.9K | 0.01% | 1363 |
|
2022
Q2 | $221K | Buy |
+3,262
| New | +$221K | 0.01% | 1590 |
|
2022
Q1 | – | Sell |
-1,880
| Closed | -$181K | – | 2101 |
|
2021
Q4 | $181K | Sell |
1,880
-2,173
| -54% | -$209K | 0.01% | 1689 |
|
2021
Q3 | $354K | Buy |
4,053
+3,054
| +306% | +$267K | 0.02% | 1097 |
|
2021
Q2 | $155K | Sell |
999
-3,555
| -78% | -$552K | 0.01% | 1448 |
|
2021
Q1 | $719K | Buy |
4,554
+3,050
| +203% | +$482K | 0.04% | 761 |
|
2020
Q4 | $349K | Sell |
1,504
-1,007
| -40% | -$234K | 0.02% | 1200 |
|
2020
Q3 | $550K | Buy |
2,511
+1,643
| +189% | +$360K | 0.03% | 947 |
|
2020
Q2 | $247K | Buy |
+868
| New | +$247K | 0.01% | 1322 |
|